Simplex Trading’s Organogenesis Holdings ORGO Stock Holding History

Simplex Trading’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.7K	Sell	4,495 -7,121	-61%	-$24.7K	﹤0.01%	7310
2025 Q4	$60.2K	Buy	+11,616	New	+$56.3K	﹤0.01%	5494
2024 Q3	–	Sell	-1,823	Closed	-$5.11K	–	9268
2024 Q2	$5K	Buy	+1,823	New	+$4.89K	﹤0.01%	7889
2023 Q2	–	Sell	-7,328	Closed	-$21.7K	–	9666
2023 Q1	$15K	Buy	7,328 +4,949	+208%	+$12.2K	﹤0.01%	7200
2022 Q4	$6K	Buy	2,379 +2,107	+775%	+$6.15K	﹤0.01%	7950
2022 Q3	$0	Buy	+272	New	+$1.23K	﹤0.01%	10615
2022 Q2	–	Sell	-10,863	Closed	-$66.9K	–	10766
2022 Q1	$82K	Buy	10,863 +10,261	+1,704%	+$79.4K	﹤0.01%	6441
2021 Q4	$5K	Buy	+602	New	+$6.39K	﹤0.01%	9540
2021 Q2	–	Sell	-1,713	Closed	-$31.9K	–	10514
2021 Q1	$31K	Buy	+1,713	New	+$23.2K	﹤0.01%	7091

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Simplex Trading's ORGO Position: Q1 2026 in Review

Simplex Trading reduced its Organogenesis Holdings (ORGO) stake by 61% in Q1 2026, selling an estimated $24.7K and leaving 4,495 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7310.

Simplex Trading first reported a position in ORGO in Q1 2021 and has held it in 9 quarters since. The position peaked at $82K in Q1 2022. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Simplex Trading held 4,495 shares of Organogenesis Holdings worth $10.7K as of Q1 2026.
Simplex Trading sold 7,121 Organogenesis Holdings shares in Q1 2026, an estimated $24.7K.
Organogenesis Holdings made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7310 holding.
Simplex Trading first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 9 quarters since.
Simplex Trading's Organogenesis Holdings position peaked at $82K in Q1 2022.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.